On Jul 29, 2021 Topas Therapeutics closed a Series B round and raised €18,000,000 from BioMedPartners, Boehringer Ingelheim Venture Fund, EMBL Ventures, Epidarex Capital, Evotec, […]
Series B – Topas Therapeutics
On Jul 29, 2021 Topas Therapeutics closed a Series B round and raised €18,000,000 from BioMedPartners, Boehringer Ingelheim Venture Fund, EMBL Ventures, Epidarex Capital, Evotec, […]